PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $22 | -12.0% | 561 | -16.4% | 0.00% | – |
Q4 2022 | $25 | -100.0% | 671 | -35.5% | 0.00% | – |
Q4 2021 | $62,000 | +19.2% | 1,041 | -33.5% | 0.00% | – |
Q1 2020 | $52,000 | -90.2% | 1,565 | -88.8% | 0.00% | -100.0% |
Q1 2019 | $533,000 | -62.6% | 14,006 | -57.8% | 0.00% | -75.0% |
Q4 2018 | $1,427,000 | +20.1% | 33,179 | +37.2% | 0.00% | 0.0% |
Q3 2018 | $1,188,000 | +2427.7% | 24,183 | +1540.6% | 0.00% | – |
Q2 2018 | $47,000 | -93.5% | 1,474 | -93.7% | 0.00% | -100.0% |
Q1 2018 | $723,000 | +7.6% | 23,213 | +57.5% | 0.03% | +10.3% |
Q4 2017 | $672,000 | -50.2% | 14,738 | -59.0% | 0.03% | -47.3% |
Q3 2017 | $1,350,000 | +53.9% | 35,959 | +32.4% | 0.06% | +5.8% |
Q4 2016 | $877,000 | +1209.0% | 27,152 | +1286.0% | 0.05% | +940.0% |
Q3 2016 | $67,000 | -77.0% | 1,959 | -77.4% | 0.01% | -73.7% |
Q2 2016 | $291,000 | +263.8% | 8,656 | +469.8% | 0.02% | +216.7% |
Q1 2016 | $80,000 | -84.7% | 1,519 | -77.7% | 0.01% | -85.4% |
Q4 2015 | $522,000 | +7357.1% | 6,804 | +3701.1% | 0.04% | +4000.0% |
Q3 2015 | $7,000 | – | 179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |